Randomized controlled trial of the effect of regular paracetamol on influenza infection

Respirology

Volumn 21, Issue 2, 2016, Pages 370-377

  Jefferies, Sarah ^a   Braithwaite, Irene ^a   Walker, Steven ^a   Weatherall, Mark ^b,c   Jennings, Lance ^d   Luck, Michelle ^d   Barrett, Kevin ^d   Siebers, Robert ^b   Blackmore, Timothy ^c   Beasley, Richard ^a,c   Perrin, Kyle ^a,b,c  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^c CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^d CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

anti pyresis; influenza; influenza like illness; paracetamol; randomized controlled trial

Indexed keywords

ANTIBIOTIC AGENT; CODEINE; NONSTEROID ANTIINFLAMMATORY AGENT; OSELTAMIVIR; PARACETAMOL; PLACEBO; PREDNISONE; ANTIPYRETIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIPYRETIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BLOOD SAMPLING; COMMUNITY ACQUIRED INFECTION; COMORBIDITY; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ETHNICITY; FATIGUE; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A RAPID TEST; INFLUENZA B; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICATION COMPLIANCE; MYALGIA; NEW ZEALAND; PAIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RHINORRHEA; SINUSITIS; SORE THROAT; SYMPTOMATOLOGY; TEMPERATURE MEASUREMENT; TONSILLITIS; VIRUS LOAD; VIRUS SHEDDING; ADOLESCENT; BODY TEMPERATURE; DRUG EFFECTS; HEALTH STATUS; INFLUENZA, HUMAN; NOSE; SYMPTOM ASSESSMENT; VIROLOGY; YOUNG ADULT;

ACETAMINOPHEN; ADOLESCENT; ADULT; ANTIPYRETICS; AREA UNDER CURVE; BODY TEMPERATURE; DOUBLE-BLIND METHOD; FEMALE; HEALTH STATUS; HUMANS; INFLUENZA, HUMAN; MALE; NOSE; SYMPTOM ASSESSMENT; VIRAL LOAD; VIRUS SHEDDING; YOUNG ADULT;

EID: 84955321836     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12685     Document Type: Article

References (31)

1. Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Pascale MW, Weintraub E, Bridges CB,. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2008; 25: 5086-5096. doi: 10.1016/j.vaccine.2007.03.046.
2. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB,. The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health 1997; 87: 1944-1950. doi: 10.2105/AJPH.87.12.1944.
3. Tran TH, Ruiz-Palacios GM, Hayden FG, Farrar J,. Patient-oriented pandemic influenza research. Lancet 2009; 373: 2085-2086. doi: http://dx.doi.org/10.1016/S0140-6736(09)61131-4.
4. Lim WS,. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health. Thorax 2007; 62 (Suppl. 1): 1-46. doi: 10.1136/thx.2006.073080.
5. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D,. The adaptive value of fever. Infect. Dis. Clin. North Am. 1996; 10: 1-20.
6. Kurosawa S, Kobune F, Okuyama K, Sugiura A,. Effects of antipyretics in rinderpest virus infection in rabbits. J. Infect. Dis. 1987; 155: 991-997. doi: 10.1093/infdis/155.5.991.
7. Vaughn LK, Veale WL, Cooper KE,. Antipyresis: its effect on mortality rate of bacterially infected rabbits. Brain Res. Bull. 1980; 5: 69-73. doi: 10.1016/0361-9230(80)90285-3.
8. van der Zee CE, van Dam RH, Dwinger RH, Nieuwenhuijs J, Zwart D,. Flurbiprofen and immunosuppression of Trypanosoma brucei infection in the goat. Vet. Immunol. Immunopathol. 1985; 8: 341-350.
9. Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R,. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. JRSM 2010; 103: 403-411. doi: 10.1258/jrsm.2010.090441.
10. Doran TF, De Angelis C, Baumgardner RA, Mellits ED,. Acetaminophen: more harm than good for chickenpox? J. Pediatr. 1989; 114: 1045-1048. doi: 10.1016/S0022-3476(89)80461-5.
11. Brandts CH, Ndjave M, Graninger W, Kremsner PG,. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997; 350: 704-709. doi: 10.1016/S0140-6736(97)02255-1.
12. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L,. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J. Infect. Dis. 1990; 162: 1277-1282. doi: 10.1093/infdis/162.6.1277.
13. Roberts NJ Jr,. Impact of temperature elevation on immunologic defenses. Rev. Infect. Dis. 1991; 13: 462-472. doi: 10.1093/clinids/13.3.462.
14. Mullbacher A,. Hyperthermia and the generation and activity of murine influenza-immune cytotoxic T cells in vitro. J. Virol. 1984; 52: 928-931.
15. Ron Y, Dougherty JP, Duff GW, Gershon RK,. The effect of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production. J. Immunol. 1984; 133: 2037-2042.
16. Shalabi EA,. Acetaminophen inhibits the human polymorphonuclear leukocyte function in vitro. Immunopharmacology 1992; 24: 37-46. doi: 10.1016/0162-3109(92)90068-N.
17. van Zyl JM, Basson K, van der Walt BJ,. The inhibitory effect of acetaminophen on the myeloperoxidase-induced antimicrobial system of the polymorphonuclear leukocyte. Biochem. Pharmacol. 1989; 38: 161-165. doi: 10.1016/0006-2952(89)90163-9.
18. Shalabi EA, al-Tuwaijri AS,. The thermal potentiation of acetaminophen-inhibited PMN oxidative metabolism in vitro. Biopharm. Drug Dispos. 1996; 17: 501-509. doi: 10.1002/(SICI)1099-081X(199608)17:6<501::AID-BDD968>3.0.CO;2-1.
19. Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, Lommel P, Kaliskova E, Borys D, Schuerman L,. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009; 374: 1339-1350. doi: 10.1016/S0140-6736(09)61208-3.
20. Dalton RM, Mullin AE, Amorim MJ, Medcalf E, Tiley LS, Digard P,. Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase-cRNA complexes. Virol. J. 2006; 3: 58. doi: 10.1186/1743-422X-3-58.
21. Giesendorf B, Bosch F, Wahn K, Rot R,. Temperature sensitivity in maturation of mammalian influenza A viruses. Virus Res. 1984; 1: 655-667. doi: 10.1016/0168-702(84)90056-X.
22. Chu CM, Tian SF, Ren GF, Zhang YM, Liu GQ,. Occurrence of temperature-sensitive influenza A viruses in nature. J. Virol. 1982; 41: 353-359.
23. REMEL. X/pect™ FLU A&B Data Sheet IFU24600, revised August 2003.
24. Anderson TP, Werno AM, Barratt K, Mahagamasekera P, Murdoch DR, Jennings LC,. Comparison of four multiplex PCR assays for the detection of viral pathogens in respiratory specimens. J. Virol. Methods 2013; 191: 118-121. doi: 10.1016/j.jviromet.2013.04.005.
25. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi K-W, Lui GCY, Wong BCK, Wong RYK, Lam W-Y, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J. Infect. Dis. 2009; 200: 492-500. doi: 10.1086/600383.
26. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK,. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 1996; 275: 295-299. doi: 10.1001/jama.1996.03530280047035.
27. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rose A, Kinnersley N, Ward P,. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355: 1845-1850. doi: 10.1016/S0140-6736(00)02288-1.
28. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 2009; 48: 1003-1032. doi: 10.1086/598513.
29. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ,. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst. Rev. 2012; (4): CD008965. doi: 10.1002/14651858.CD008965.pub3.
30. Ryan PB, Rush DR, Nicholas TA, Graham DG,. A double-blind comparison of fenoprofen calcium, acetaminophen, and placebo in the palliative treatment of common nonbacterial upper respiratory infections. Curr. Ther. Res. Clin. Exp. 1987; 41: 17-23.
31. Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VS, Voelker M,. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin. Ther. 2005; 27: 993-1003. doi: 10.1016/j.clinthera.2005.06.002.